233 related articles for article (PubMed ID: 20521434)
1. AAA- a further step towards a moratorium for aspirin in the primary prevention.
Minar E
Vasa; 2010 May; 39(2):119-122. PubMed ID: 20521434
[No Abstract] [Full Text] [Related]
2. Aspirin for Primary Prevention of Cardiovascular Disease.
Kheiri B; Barbarawi M; Bachuwa G; Shapiro MD
Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005846. PubMed ID: 31163982
[No Abstract] [Full Text] [Related]
3. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials.
Soejima H; Morimoto T; Saito Y; Ogawa H
Thromb Haemost; 2010 Dec; 104(6):1085-8. PubMed ID: 20941462
[No Abstract] [Full Text] [Related]
4. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
Godley RW; Hernandez-Vila E
Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
[No Abstract] [Full Text] [Related]
5. Aspirin in primary prevention: USPSTF recommendations.
Aalbers J
Cardiovasc J Afr; 2010; 21(3):176. PubMed ID: 20532445
[No Abstract] [Full Text] [Related]
6. What have we learned about using aspirin for primary prevention from the ASCEND and ARRIVE trials?
Tousoulis D
Cardiovasc Res; 2019 Feb; 115(2):e15-e16. PubMed ID: 30668678
[No Abstract] [Full Text] [Related]
7. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
Matthys F; De Backer T; De Backer G; Stichele RV
Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
[TBL] [Abstract][Full Text] [Related]
9. Advancing the science of aspirin in primary prevention of vascular events.
Cardiovasc J Afr; 2007; 18(5):347-8. PubMed ID: 17985039
[No Abstract] [Full Text] [Related]
10. On the potential contribution of aspirin to healthy ageing programmes.
Morgan GP
Age Ageing; 2016 Mar; 45(2):e1-3. PubMed ID: 22101149
[No Abstract] [Full Text] [Related]
11. Impact of acetylsalicylic acid on primary prevention of cardiovascular diseases: A meta-analysis of randomized trials.
Upadhaya S; Madala S; Baniya R; Saginala K; Khan J
Eur J Prev Cardiol; 2019 May; 26(7):746-749. PubMed ID: 30861689
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.
Volpe M; Battistoni A; Gallo G; Coluccia R; De Caterina R
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):331-339. PubMed ID: 28573479
[TBL] [Abstract][Full Text] [Related]
13. Aspirin for the primary prevention of vascular events?
Morgan G
Public Health; 2009 Dec; 123(12):787-8. PubMed ID: 19914670
[No Abstract] [Full Text] [Related]
14. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
[TBL] [Abstract][Full Text] [Related]
15. [Aspirin for primary prevention of asymptomatic atherosclerosis].
Lévesque H
J Mal Vasc; 2002 Dec; 27(5):263-6. PubMed ID: 12525771
[No Abstract] [Full Text] [Related]
16. Aspirin for the primary prevention of adverse cardiovascular events.
Estes K; Thomure J
Crit Care Nurs Q; 2008; 31(4):324-39. PubMed ID: 18815480
[TBL] [Abstract][Full Text] [Related]
17. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
18. Aspirin for primary cardiovascular disease prevention: time to re-evaluate guidelines?
Barmanray R; Hamblin PS
Intern Med J; 2019 Jan; 49(1):133-134. PubMed ID: 30680892
[No Abstract] [Full Text] [Related]
19. Aspirin as preventive therapy in patients with asymptomatic vascular disease.
Berger JS
JAMA; 2010 Mar; 303(9):880-2. PubMed ID: 20197537
[No Abstract] [Full Text] [Related]
20. [Primary cardiovascular prevention with aspirin].
Seguí Díaz M; Escobar C; Divisón JA
Semergen; 2015; 41(5):279-81. PubMed ID: 25622997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
